Business Description
OrbusNeich Medical Group Holdings Ltd
ISIN : KYG6773B1005
Total Employee Number:
1,477Compare
Compare
Traded in other countries / regions
06929.Hong KongQ8T.Germany Index Membership
Hong Kong Stock Connect IPO Date
2022-12-23Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 29.44 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.13 | |||||
Interest Coverage | 247.37 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.87 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 22.8 | |||||
3-Year EPS without NRI Growth Rate | 23.2 | |||||
3-Year FCF Growth Rate | -62.1 | |||||
3-Year Book Growth Rate | 8.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.47 | |||||
9-Day RSI | 39.64 | |||||
14-Day RSI | 45.2 | |||||
3-1 Month Momentum % | -14.1 | |||||
6-1 Month Momentum % | 0.68 | |||||
12-1 Month Momentum % | -17.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.07 | |||||
Quick Ratio | 8.18 | |||||
Cash Ratio | 6.14 | |||||
Days Inventory | 388.68 | |||||
Days Sales Outstanding | 88.84 | |||||
Days Payable | 25.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.13 | |||||
Dividend Payout Ratio | 0.28 | |||||
Forward Dividend Yield % | 4.18 | |||||
5-Year Yield-on-Cost % | 3.13 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.7 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.6 | |||||
Operating Margin % | 23.43 | |||||
Net Margin % | 22.33 | |||||
EBITDA Margin % | 25.92 | |||||
FCF Margin % | 0.57 | |||||
OCF Margin % | 9.96 | |||||
ROE % | 10.55 | |||||
ROA % | 9.63 | |||||
ROIC % | 17.74 | |||||
3-Year ROIIC % | 12.4 | |||||
ROC (Joel Greenblatt) % | 38.48 | |||||
ROCE % | 12.02 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 9.25 | |||||
Forward PE Ratio | 8.2 | |||||
PE Ratio without NRI | 9.08 | |||||
Price-to-Owner-Earnings | 22.14 | |||||
PEG Ratio | 0.22 | |||||
PS Ratio | 2.07 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 1.02 | |||||
Price-to-Free-Cash-Flow | 383 | |||||
Price-to-Operating-Cash-Flow | 20.82 | |||||
EV-to-EBIT | 4.17 | |||||
EV-to-Forward-EBIT | 4.5 | |||||
EV-to-EBITDA | 4.17 | |||||
EV-to-Forward-EBITDA | 3.9 | |||||
EV-to-Revenue | 1.08 | |||||
EV-to-Forward-Revenue | 0.7 | |||||
EV-to-FCF | 191.11 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.38 | |||||
Price-to-Graham-Number | 0.64 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
| Price-to-Net-Cash | 2.55 | |||||
Earnings Yield (Greenblatt) % | 23.98 | |||||
FCF Yield % | 0.27 | |||||
Forward Rate of Return (Yacktman) % | 23.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OrbusNeich Medical Group Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,527.627 | ||
| EPS (TTM) (HK$) | 0.414 | ||
| Beta | 0.714 | ||
| 3-Year Sharpe Ratio | -0.41 | ||
| 3-Year Sortino Ratio | -0.55 | ||
| Volatility % | 24.08 | ||
| 14-Day RSI | 45.2 | ||
| 14-Day ATR (HK$) | 0.086478 | ||
| 20-Day SMA (HK$) | 3.92775 | ||
| 12-1 Month Momentum % | -17.38 | ||
| 52-Week Range (HK$) | 3.45 - 5.1 | ||
| Shares Outstanding (Mil) | 823.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OrbusNeich Medical Group Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OrbusNeich Medical Group Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.080000 Cash Dividend | 2026-09-18 | In 12 days | ||
| HKD 0.120000 Cash Dividend | 2026-06-10 | 4.09 (-0.49%) | ||
| General meeting for 2025 | 2026-05-27 11:00 | 4.29 (+0.23%) | ||
| Annual report for 2025 | 2026-04-16 | 4.06 (+1.50%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-06 | 3.67 (+4.26%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 4.28 (-0.47%) | ||
| HKD 0.150000 Cash Dividend | 2025-09-18 | 4.56 (+3.17%) | ||
| Second quarter earnings results for 2025 | 2025-08-15 | 5.03 (+0.60%) | ||
| HKD 0.100000 Cash Dividend | 2025-05-29 | 3.75 (+1.63%) | ||
| General meeting for 2024 | 2025-05-27 11:00 | 3.72 (-5.58%) |
Show
Entries
OrbusNeich Medical Group Holdings Ltd Frequently Asked Questions
What is OrbusNeich Medical Group Holdings Ltd(HKSE:06929)'s stock price today?
The current price of HKSE:06929 is HK$3.83. The 52 week high of HKSE:06929 is HK$5.10 and 52 week low is HK$3.45.
When is next earnings date of OrbusNeich Medical Group Holdings Ltd(HKSE:06929)?
The next earnings date of OrbusNeich Medical Group Holdings Ltd(HKSE:06929) is 2026-11-14 Est..
Does OrbusNeich Medical Group Holdings Ltd(HKSE:06929) pay dividends? If so, how much?
The Dividend Yield %  of OrbusNeich Medical Group Holdings Ltd(HKSE:06929) is 3.13% (As of Today), Highest Dividend Payout Ratio of OrbusNeich Medical Group Holdings Ltd(HKSE:06929) was 0.28. The lowest was 0.25. And the median was 0.25. The  Forward Dividend Yield % of OrbusNeich Medical Group Holdings Ltd(HKSE:06929) is 4.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on OrbusNeich Medical Group Holdings Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers